Potential for Fundamental Change in the Treatment of Brain Cancer

Ads

You May Also Like

Apricus Biosciences Announces the Initiation of Vitaros Drug-Device Human Factors Study

SAN DIEGO, May 04, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...

Data from Prospective Phase 2 Study Investigating Delcath’s PHP Therapy presented at CIRSE 2018

Positive Results Observed in Study Endpoints Comparable to Endpoints in Delcath Registration TrialNEW YORK, ...

Orion Group Financial Statement documents 2017 and Corporate Governance Statement published

ORION CORPORATION           STOCK EXCHANGE RELEASE         26 FEBRUARY 2018 at 13.00 EET                       Orion Group ...